[go: up one dir, main page]

NO975738L - Modulering av kalsiumkanaler - Google Patents

Modulering av kalsiumkanaler

Info

Publication number
NO975738L
NO975738L NO975738A NO975738A NO975738L NO 975738 L NO975738 L NO 975738L NO 975738 A NO975738 A NO 975738A NO 975738 A NO975738 A NO 975738A NO 975738 L NO975738 L NO 975738L
Authority
NO
Norway
Prior art keywords
calcium channels
alkyl
modulation
phenyl
ochzch
Prior art date
Application number
NO975738A
Other languages
English (en)
Other versions
NO975738D0 (no
Inventor
Nancy L Bowling
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO975738D0 publication Critical patent/NO975738D0/no
Publication of NO975738L publication Critical patent/NO975738L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/56—Preparation of melamine
    • C07D251/58—Preparation of melamine from cyanamide, dicyanamide or calcium cyanamide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Hydrogenated Pyridines (AREA)
  • Soft Magnetic Materials (AREA)

Abstract

Det er beskrevet en fremgangsmåte for å modulere kalsiumkanaler, ved økning av densiteten av kalsiumkanaler i vaskulært- og hjertevev uten noen endringer i inotropisk eller pressorrespons, som innbefatter administrering til et varmblodig dyr som har behov for dette av en farmasøytisk effektiv mengde av en forbindelse som har formel (I) OCHZCH2R2 R'0' (D hvor R' og R.3 uavhengig av hverandre er hydrogen, C]-C4 alkyl, -CO-(Ci-C6 alkyl), eller -Ct^Ar, -CO-Ar, hvor Ar er fenyl eller substituert fenyl; R.2 er valgt fra gruppen bestående av pyrrolidin, heksametylenimino og piperidino; eller et farmasøytisk akseptabelt salt derav.
NO975738A 1995-06-07 1997-12-05 Modulering av kalsiumkanaler NO975738L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,317 US5532254A (en) 1995-06-07 1995-06-07 Modulation of calcium channels using benzothiophenes
PCT/US1996/009161 WO1996039833A1 (en) 1995-06-07 1996-06-04 Modulation of calcium channels

Publications (2)

Publication Number Publication Date
NO975738D0 NO975738D0 (no) 1997-12-05
NO975738L true NO975738L (no) 1997-12-05

Family

ID=23927688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975738A NO975738L (no) 1995-06-07 1997-12-05 Modulering av kalsiumkanaler

Country Status (19)

Country Link
US (1) US5532254A (no)
EP (1) EP0873051B1 (no)
JP (1) JPH11506787A (no)
KR (1) KR19990022365A (no)
CN (1) CN1094758C (no)
AT (1) ATE272315T1 (no)
AU (1) AU692400B2 (no)
CA (1) CA2222739A1 (no)
CZ (1) CZ288547B6 (no)
DE (1) DE69633070D1 (no)
EA (1) EA000873B1 (no)
HU (1) HUP9900860A3 (no)
IL (1) IL122282A (no)
NO (1) NO975738L (no)
NZ (1) NZ310177A (no)
PL (1) PL323930A1 (no)
RO (1) RO117892B1 (no)
UA (1) UA42837C2 (no)
WO (1) WO1996039833A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840747A (en) * 1995-06-07 1998-11-24 Eli Lilly And Company Calcium channel antagonists
US5846983A (en) † 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
ME00074B (me) * 1996-03-26 2010-10-10 Lilly Co Eli Benzotiofeni, formulacije koje ih sadrže i proizvod
DE69828522T2 (de) 1997-04-30 2005-12-15 Eli Lilly And Co., Indianapolis Antithrombotische mittel
CA2288144A1 (en) 1997-04-30 1998-11-05 Eli Lilly And Company Antithrombotic agents
EP0980366B1 (en) 1997-04-30 2004-06-09 Eli Lilly And Company Antithrombotic agents
US6350774B1 (en) * 1997-04-30 2002-02-26 Eli Lilly And Company Antithrombotic agents
US5760030A (en) * 1997-06-30 1998-06-02 Eli Lilly And Company Benzothiophene compounds and methods of use
US6284756B1 (en) 1998-04-30 2001-09-04 Eli Lilly And Company Antithrombotic agents
ATE229520T1 (de) * 1998-10-28 2002-12-15 Lilly Co Eli Benzothiophenderivate als antithrombotische mitteln und zwischenprodukte
EP1533295A1 (en) * 2003-11-24 2005-05-25 Newron Pharmaceuticals S.p.A. Cyclopentyl Derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
CN1058390C (zh) * 1993-10-15 2000-11-15 伊莱利利公司 苯并噻吩类化合物的用途
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y

Also Published As

Publication number Publication date
JPH11506787A (ja) 1999-06-15
CZ288547B6 (cs) 2001-07-11
WO1996039833A1 (en) 1996-12-19
CA2222739A1 (en) 1996-12-19
AU6091896A (en) 1996-12-30
HUP9900860A2 (hu) 1999-09-28
KR19990022365A (ko) 1999-03-25
CN1094758C (zh) 2002-11-27
DE69633070D1 (de) 2004-09-09
CN1192121A (zh) 1998-09-02
CZ388097A3 (cs) 1998-06-17
IL122282A0 (en) 1998-04-05
IL122282A (en) 2001-08-08
RO117892B1 (ro) 2002-09-30
EA000873B1 (ru) 2000-06-26
EP0873051A4 (en) 1999-01-07
PL323930A1 (en) 1998-04-27
NO975738D0 (no) 1997-12-05
UA42837C2 (uk) 2001-11-15
AU692400B2 (en) 1998-06-04
US5532254A (en) 1996-07-02
ATE272315T1 (de) 2004-08-15
EP0873051A1 (en) 1998-10-28
EP0873051B1 (en) 2004-08-04
EA199800019A1 (ru) 1998-06-25
NZ310177A (en) 2000-06-23
HUP9900860A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
NO975738L (no) Modulering av kalsiumkanaler
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
NO944919L (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
NO944927L (no) Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom
CA2336412A1 (en) Medicament for treatment of diabetes
ATE168887T1 (de) Hemmung von dysfunctionalen uterusblutungen
UA32427C2 (uk) Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
NO975580L (no) Fremgangsmåte for å inhibere melanom
NO973367L (no) Fremgangsmåte for å inhibere miljömessige östrogen
NO981578L (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I
NO973609L (no) Fremgangsmåte for å inhibere effektene av IL-6
NO970783L (no) Fremgangsmåte for å hindre endometrialkreft
NO971794L (no) Fremgangsmåte for hemming av tilstander forbundet med bradykinin
NO971029L (no) Fremgangsmåter for hemming av endometriale metoser
NO975561L (no) Kalsiumkanalantagonister
NO983453L (no) Fremgangsmåte for ökning av sfinkterfunksjon
NO973103L (no) Fremgangsmåte for inhibering av veksthormoneffekter
NO944909L (no) Fremgangsmåter for inhibering av mannlig infertilitet
MX9709542A (es) Modulacion de los canales de calcio.
ATE200623T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
NO983451L (no) FremgangsmÕte for hemming av colontumorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application